Literature DB >> 497670

Decreased serum 24,25-dihydroxy vitamin D concentrations in children receiving chronic anticonvulsant therapy.

Y Weisman, A Fattal, Z Eisenberg, S Harel, Z Spirer, A Harell.   

Abstract

Serum 24,25-dihydroxy vitamin D (24,25(OH)2D) and 25-hydroxy vitamin D (25-OHD) concentrations and the ratio between the two were measured in 31 Israeli children and adolescents receiving long-term treatment with phenobarbitone or phenytoin and in controls. 24,25 (OH)2D concentrations were significantly depressed in the patients, although the 25-OHD concentrations were similar to those in the healthy controls. In four patients with radiological evidence of osteopenia very low serum 24,25(OH)2D concentrations and serum 24,25(OH)2D: 25-OHD ratios were recorded. The findings suggest that 24,25(OH)2D deficiency may play an important part in the pathogenesis of osteomalacia in patients treated with anticonvulsant drugs and provide further indirect evidence that 24,25(OH)2D is important for normal bone structure.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 497670      PMCID: PMC1596165          DOI: 10.1136/bmj.2.6189.521

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  Effect of phenobarbitone treatment on vitamin D metabolism in mammals.

Authors:  J Silver; G Neale; G R Thompson
Journal:  Clin Sci Mol Med       Date:  1974-04

2.  Intestinal absorption of vitamin D 3 in epileptic patients and phenobarbital-treated rats.

Authors:  K Schaefer; D Kraft; D von Herrath; A Opitz
Journal:  Epilepsia       Date:  1972-08       Impact factor: 5.864

3.  Disturbance of calcium metabolism by anticonvulsant drugs.

Authors:  A Richens; D J Rowe
Journal:  Br Med J       Date:  1970-10-10

4.  24, 25-dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation.

Authors:  A Ornoy; D Goodwin; D Noff; S Edelstein
Journal:  Nature       Date:  1978-11-30       Impact factor: 49.962

5.  Measurement of 24,25 dihydroxyvitamin D in sera of neonates and children.

Authors:  Y Weisman; E Reiter; A Rott
Journal:  J Pediatr       Date:  1977-12       Impact factor: 4.406

6.  Diphenylhydantoin: effects on calcium metabolism in the chick.

Authors:  M Villareale; L V Gould; R H Wasserman; A Barr; R T Chiroff; W H Bergstrom
Journal:  Science       Date:  1974-02-15       Impact factor: 47.728

7.  Vitamin D metabolites and bone mineralization in man.

Authors:  P Bordier; H Rasmussen; P Marie; L Miravet; J Gueris; A Ryckwaert
Journal:  J Clin Endocrinol Metab       Date:  1978-02       Impact factor: 5.958

8.  Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs.

Authors:  W Jubiz; M R Haussler; T A McCain; K G Tolman
Journal:  J Clin Endocrinol Metab       Date:  1977-04       Impact factor: 5.958

  8 in total
  6 in total

1.  On the pathogenesis of anticonvulsant-drug-induced alterations of calcium metabolism.

Authors:  K Kruse
Journal:  Eur J Pediatr       Date:  1982-05       Impact factor: 3.183

2.  Calcium metabolism and vitamin D metabolite levels in children receiving anticonvulsant drugs.

Authors:  E Keck; B Gollnick; D Reinhardt; D Karch; H Peerenboom; H L Krüskemper
Journal:  Eur J Pediatr       Date:  1982-09       Impact factor: 3.183

Review 3.  Antiepileptic drug toxicity: definition and mechanism of action.

Authors:  E Beghi; R Di Mascio
Journal:  Ital J Neurol Sci       Date:  1986-04

Review 4.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

5.  Factors causing rickets in institutionalised handicapped children on anticonvulsant therapy.

Authors:  Y Morijiri; T Sato
Journal:  Arch Dis Child       Date:  1981-06       Impact factor: 3.791

Review 6.  Drug-vitamin D interactions: a systematic review of the literature.

Authors:  Kim Robien; Sarah J Oppeneer; Julia A Kelly; Jill M Hamilton-Reeves
Journal:  Nutr Clin Pract       Date:  2013-01-10       Impact factor: 3.080

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.